Printer Friendly

ROCHESTER MEDICAL REPORTS THIRD QUARTER RESULTS

 ROCHESTER MEDICAL REPORTS THIRD QUARTER RESULTS
 STEWARTVILLE, Minn., Aug. 11 /PRNewswire/ -- Rochester Medical


Corporation (NASDAQ: ROCM) today announced sales and net income for the third quarter and nine months ended June 30, 1992. Net sales for the third quarter and nine months ended June 30, 1992 were $94,770 and $337,328. The company reported a net loss for the third quarter and nine months ended June 30, 1992, of $206,231, or $.08 per share, and $425,143, or $.16 per share, respectively, compared to net income of $360,833 or $.21 per share and $135,515, or $.08 per share for the year earlier periods, respectively.
 Anthony J. Conway, ROCM's president and CEO, said, "Sales through June 30, 1992, consisted primarily of the external catheter to our exclusive licensee, Mentor Corporation. We expect to begin selling ROCM's own brands of catheters in September 1992."
 ROCM develops and manufactures improved urological catheters including all silicone Foley catheters and all silicone male external catheters.
 ROCHESTER MEDICAL CORPORATION
 Third Quarter Ended Nine Months Ended
 6/30/92 6/30/91 6/30/92 6/30/91
 Net sales $94,770 -- $337,328 --
 Net income (loss)(a) (206,231) 360,833 (425,143) 135,515
 Net income (loss) per
 share (a) $(.08) $.21 $(.16) $.08
 Average common shares
 outstanding 2,660,000 1,740,000 2,660,000 1,630,000
 (a) Commercial sales commenced in November 1991. Income during fiscal 1991 included a $500,000 one-time license fee from Mentor Corporation.
 -0- 8/11/92
 /CONTACT: Anthony J. Conway of Rochester Medical, 507-533-4203/
 (ROCM) CO: Rochester Medical Corporation ST: Minnesota IN: MTC SU: ERN


AL -- MN008 -- 9004 08/11/92 13:11 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 11, 1992
Words:282
Previous Article:X/OPEN AND OSF AGREE TO INCORPORATE DCE INTO COMMON APPLICATIONS ENVIRONMENT
Next Article:CABOT ISSUES $60 MILLION DEBT UNDER $300 MILLION SHELF REGISTRATION
Topics:


Related Articles
ROCHESTER MEDICAL REPORTS SECOND QUARTER RESULTS
ROCHESTER MEDICAL REPORTS THIRD QUARTER RESULTS
ROCHESTER MEDICAL REPORTS FOURTH QUARTER PROFIT
ROCHESTER MEDICAL REPORTS FOURTH QUARTER PROFIT
ROCHESTER MEDICAL REPORTS FIRST QUARTER PROFIT
Rochester Medical Reports Operating Results, Developments
Rochester Medical Reports Sales, Developments
Rochester Medical Reports Sales, Developments
Correction of Year-to-Date Information in Rochester Medical Third Quarter Fiscal 2000 Results Release.
Rochester Medical Reports Third Quarter Fiscal 2001 Results; New Agreement With Mentor Corporation.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters